Central Laboratories Products/Services

1. Suvoda RTSM (IRT) 9/16/2025

   A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.

2. The Asia Drug Development Advantage 8/8/2024

   Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.

3. Signal Management Services 8/2/2024

   ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.

4. Commercialization And Outcomes 5/17/2018

   ICON Commercialization & Outcomes (ICO) optimizes the value of drugs and medical devices through innovative strategies and tactics that reflect evolving evidentiary, regulatory, and reimbursement requirements.

5. AI-Powered Workflows: Accelerating Trial Execution 4/1/2026

   What can 22,000 people with an AI-mindset accomplish?

   Speed without shortcuts

   AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

   Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:

   1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
   2. Apply insights with agility to enable better decision-making
   3. Enhance data handling to drive first-time quality through content generation and workflow automation
6. BIOGRID: The Most Effective Way To Graphically Represent Data-Driven Insights 9/28/2022

   Bioforum’s clinical research experts have developed an intuitive and easy-to-navigate analytics and visualization platform.
   BioGRID brings clinical trial data together in a clear, focused manner to drive smart decision-making processes.

7. Revvity Signals Software Signals™ Medical Review 8/28/2017

   See our exciting new solution for medical monitors, Revvity Signals Software Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.

8. Enable Value-Based Evaluation Of Medicines 3/28/2025

   Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.

9. Electronic Data Capture (EDC) System: Leverage Flexibility And Speed 8/11/2025

   Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.

   They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.

   Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.

10. Drug Safety And Pharmacovigilance Services 4/2/2026

    Navigating drug safety in the era of innovation-driven medicine

    The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.